Skip to content

Clinical trials

Not yet recruiting Scleroderma, Systemic trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Scleroderma, Systemic Status: Not yet recruiting Country / region: China Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20241
20253
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Not yet recruiting12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
PersonGen BioTherapeutics (Suzhou) Co., Ltd.2
Antengene Biologics Limited1
Changzhou No.2 People's Hospital1
First Affiliated Hospital of Wenzhou Medical University1
Institute of Hematology & Blood Diseases Hospital, China1
Nanjing Bioheng Biotech Co., Ltd.1
Qiubai Li1
Shenzhen MagicRNA Biotechnology Co., Ltd1
The Affiliated Hospital of Qingdao University1
Toll Biotech Co. Ltd. (Beijing)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Scleroderma, Systemic12
Lupus Erythematosus, Systemic8
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis4
Myositis4
Sjogren's Syndrome4
Autoimmune Diseases3
Antiphospholipid Syndrome2
Immunoglobulin G4-Related Disease2
Myasthenia Gravis2
Anemia, Hemolytic, Autoimmune1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.